Success Metrics

Clinical Success Rate
75.0%

Based on 6 completed trials

Completion Rate
75%(6/8)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
2(25%)

Phase Distribution

Ph phase_2
2
25%
Ph phase_4
6
75%

Phase Distribution

0

Early Stage

2

Mid Stage

6

Late Stage

Phase Distribution8 total trials
Phase 2Efficacy & side effects
2(25.0%)
Phase 4Post-market surveillance
6(75.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

6 of 8 finished

Non-Completion Rate

25.0%

2 ended early

Currently Active

0

trials recruiting

Total Trials

8

all time

Status Distribution
Completed(6)
Terminated(2)

Detailed Status

Completed6
Terminated2

Development Timeline

Analytics

Development Status

Total Trials
8
Active
0
Success Rate
75.0%
Most Advanced
Phase 4

Trials by Phase

Phase 22 (25.0%)
Phase 46 (75.0%)

Trials by Status

terminated225%
completed675%

Recent Activity

0 active trials
Showing 5 of 8
completedphase_4

A Study of the Effectiveness And Safety Of Lidoderm® As Add-On Treatment in Patients With Postherpetic Neuralgia, Diabetic Neuropathy, or Low Back Pain

NCT00904020
completedphase_4

Topical Lidocaine Patch in Low Back Pain

NCT00904540
completedphase_2

A Study Comparing The Efficacy And Safety Of Lidocaine 5% Patch With Placebo In Patients With Chronic Axial Low Back Pain

NCT00904111
completedphase_4

Lidoderm® (Lidocaine Patch 5%) in Diabetic and Idiopathic Neuropathy

NCT00903851
completedphase_4

Pilot Study of the Efficacy and Safety of Lidoderm Patch in the Treatment of Low Back Pain

NCT00904475
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT00904020Phase 4

A Study of the Effectiveness And Safety Of Lidoderm® As Add-On Treatment in Patients With Postherpetic Neuralgia, Diabetic Neuropathy, or Low Back Pain

Completed
NCT00904540Phase 4

Topical Lidocaine Patch in Low Back Pain

Completed
NCT00904111Phase 2

A Study Comparing The Efficacy And Safety Of Lidocaine 5% Patch With Placebo In Patients With Chronic Axial Low Back Pain

Completed
NCT00903851Phase 4

Lidoderm® (Lidocaine Patch 5%) in Diabetic and Idiopathic Neuropathy

Completed
NCT00904475Phase 4

Pilot Study of the Efficacy and Safety of Lidoderm Patch in the Treatment of Low Back Pain

Completed
NCT00904605Phase 4

Lidocaine Patch Versus Celecoxib in Pain From Osteoarthritis of the Knee

Terminated
NCT00904397Phase 4

Lidocaine Patch 5% Versus Celecoxib 200 mg in Chronic Axial Low Back Pain

Terminated
NCT00904462Phase 2

Pilot Study of Lidocaine 5% Patch Versus Placebo in Patients With Osteoarthritis Pain of the Knee

Completed

All 8 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
8